Cell Therapy Manufacturing market Professional Survey Report by 2035 Owing to the intricacies associated with the manufacturing processes, requirement of advanced production facilities and the growing demand for cell therapy products, developers are actively outsourcing certain manufacturing operations and automation technologies, in addition to expanding their in-house capabilities. The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:  Type of Cell Therapy  T cell therapies  Dendritic cell therapies  NK cell therapies  Stem cell therapies  Source of Cell  Autologous  Allogeneic  Scale of Operation  Clinical  Commercial  Purpose of Manufacturing  In-house Manufacturing  Contract Manufacturing  Geographical Regions  North America  Europe  Asia Pacific  Rest of the World The Cell Therapy Manufacturing Market (5th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:  AGC Biologics  BioNTech Innovative Manufacturing Services  Cell and Gene Therapy Catapult  Cell Therapies  Center for Cell and Gene Therapy, Baylor College of Medicine  Center for Cell Manufacturing Ireland, National University of Ireland  Charles River Laboratories  Clinical Cell and Vaccine Production Facility, University of Pennsylvania  FUJIFILM Cellular Dynamics  Guy’s and St. Thomas GMP Facility, Guy’s Hospital  KBI Biopharma  Laboratory for Cell and Gene Medicine, Stanford University  Lonza  MEDINET  Minaris Regenerative Medicine  Molecular and Cellular Therapeutics, University of Minnesota  Newcastle Cellular Therapies Facility, Newcastle University  Nikon CeLL innovation  Rayne Cell Therapy Suite, King’s College London  RoslinCT  Scottish National Blood Transfusion Service, Scottish Centre of Regenerative Medicine  Sydney Cell and Gene Therapy  Thermofisher Scientific  WuXi AppTec Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Overview 5. Regulatory Landscape 6. Roadmaps for Overcoming Challenges 7. Automation Technologies for Cell Therapy Manufacturing 8. Profiles: Industry Players 9. Profiles: Non-Industry Players 10. Role of Non-Profit Organizations 11. Clinical Trial Analysis 12. Partnerships and Collaborations 13. Recent Expansions 14. Big Pharma Initiatives 15. Capacity Analysis 16. Demand Analysis 17. Cost Price Analysis 18. Make Versus Buy Decision Making Framework 19. Total Cost of Ownership 20. Market Sizing and Opportunity Analysis 21. Key Insights 22. SWOT Analysis 23. Concluding Remarks 24. Survey Analysis 25. Interview Transcripts 26. Appendix 1: Tabulated Data 27. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html You may also be interested in the following titles: Conjugation and Labeling Services Market Bispecific Antibodies Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 [email protected] #CellTherapyManufacturingSize #cellulartherapies #celltherapymanufacturing